Chronotropic Incompetence During Exercise in Obese Adolescents: Clinical Implications and Pathophysiology
NCT03516721 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120
Last updated 2020-02-11
Summary
A reduction in peak heart rate (HR) and suppressed HR response during exercise is highly prevalent in obese populations. This phenomenon is also known as chronotropic incompetence (CI). In adult obese individuals, CI is independently related to elevated risk for major adverse cardiovascular events and premature death. Despite the established association between CI and prognosis in adult populations, the prognostic relevance of CI in adolescents with obesity has however deserved no attention, but is important. CI during exercise testing may indicate various, yet undetected anomalies, such as altered blood catecholamine and/or potassium concentrations during exercise, structural myocardial abnormalities or ventricular stiffness, impaired baroreflex sensitivity and cardiovascular autonomic dysfunction, atherosclerosis, or cardiac electrophysiological anomalies, which all have been detected in obese children and adolescents. However, whether CI during exercise testing may be a sensitive and specific indicator for these anomalies in obese adolescents has not been studied yet. In addition, the exact physiology behind obesity and development of heart disease remains to be studied in greater detail in obese adolescents. In this project, we examine the prevalence of CI (during maximal cardiopulmonary exercise testing, CPET) in 60 obese adolescents (aged 12-16 years) vs. 60 lean adolescents, and study the association between CI and changes in CPET parameters, lactate, catecholamine and potassium concentrations during CPET, biochemical variables, and cardiac electrophysiology (by ECG recording). In addition, the relation between CI and cardiac function (echocardiography) will be examined in a subgroup (29 lean and 29 obese) of these adolescents. In this regard, the diagnostic value of HR (responses) during maximal exercise testing will be clarified in obese adolescents, and the physiology behind the elevated risk for heart disease in obese adolescents can be explored.
Conditions
- Obesity
- Adolescent Obesity
Interventions
- OTHER
-
the prevalence of chronotropic incompetence CI during maximal cardiopulmonary exercise testing, CPET
Sponsors & Collaborators
-
Jessa Hospital
collaborator OTHER -
Hasselt University
lead OTHER
Principal Investigators
-
Dominique Hansen, prof. dr. · Hasselt University
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-11-01
- Primary Completion
- 2017-05-01
- Completion
- 2019-08-31
Countries
- Belgium
Study Locations
More Related Trials
-
Pulse Reduction On Beta-blocker and Ivabradine Therapy
NCT02973594 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of NT-proBNP Guided Treatment of Chronic Heart Failure
NCT00149422 ·Status: COMPLETED ·Phase: NA
-
Effect of Beta Blockade on Left Ventricular Remodeling and Function in Moderate to Severe Asymptomatic Aortic Regurgitation
NCT01157572 ·Status: COMPLETED ·Phase: PHASE4
-
Exercise Improve Sympathetic Modulation in Chronic Heart Failure Patients
NCT02219451 ·Status: COMPLETED ·Phase: PHASE4
-
CIQTP Prolongation : Role and Mechanism in Sudden Cardiac Death
NCT03387072 ·Status: COMPLETED
-
The Predictive Value of the Heart Rate Response to Breathing Maneuvers for Inducible Myocardial Perfusion Deficits
NCT05516615 ·Status: COMPLETED
-
The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy.
NCT03532802 ·Status: COMPLETED ·Phase: PHASE2
-
Pathophysiology of Orthostatic Intolerance
NCT00608725 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Influence of Heart Rate Reduction Upon Central Arterial Pressure in Younger and Older Healthy Individuals
NCT01029223 ·Status: WITHDRAWN ·Phase: PHASE4
-
Metoprolol in Acute Myocardial Infarction. A PK/PD Study
NCT01523054 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Ponesimod in Healthy Adult Participants Receiving Propranolol at Steady State
NCT03882255 ·Status: COMPLETED ·Phase: PHASE1
-
Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
NCT05593055 ·Status: RECRUITING ·Phase: PHASE4
-
Effects of Inorganic Nitrate and Intensity of Exercise on Cardiovascular Health in Post-Menopausal Females
NCT05221905 ·Status: COMPLETED ·Phase: PHASE1
-
Acute Effects of Beet Juice Consumption on Exercise Capacity in Heart Failure
NCT01946542 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
The Development of Tolerance to α1-Adrenoceptor Blockade With Chronic Carvedilol Treatment
NCT00585091 ·Status: COMPLETED ·Phase: NA
-
Influence of Inotropic Choice on Morbidity and Mortality in Complex Pediatric Heart Surgery
NCT04380181 ·Status: COMPLETED
-
Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy
NCT05366101 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy
NCT04133532 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Exercise in OI
NCT00770484 ·Status: COMPLETED ·Phase: NA
-
Cardiovascular Effects of Selective I(f)-Channel Blockade
NCT00865917 ·Status: UNKNOWN ·Phase: PHASE2
-
The Effects of Clonidine on the Diuretic Response in Cirrhotic Patients
NCT00356226 ·Status: COMPLETED ·Phase: NA
-
Aldosterone Antagonism and Microvascular Function
NCT01887119 ·Status: TERMINATED ·Phase: PHASE4
-
Ability of Metoprolol to Alter the Exercise Induced Elevation of Catecholamines
NCT00885651 ·Status: UNKNOWN ·Phase: PHASE4
-
The Pathophysiology of Orthostatic Hypotension
NCT00748059 ·Status: COMPLETED ·Phase: PHASE1
-
Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease
NCT07268170 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2/PHASE3